Company Filing History:
Years Active: 2021
Title: Fuzhi Zhang: Innovator in Pharmaceutical Science
Introduction
Fuzhi Zhang is an accomplished inventor based in Suzhou, China, recognized for his contributions to pharmaceutical innovations. With a patent to his name, Zhang has made significant strides in the development of improved pharmaceutical compositions.
Latest Patents
Zhang's notable patent is titled "Salt of cetagliptin, preparation method thereof, pharmaceutical composition, and use thereof." This invention specifically pertains to a salt of a compound represented by a specific formula. The patent details that the salt can exist in various forms, including crystalline or amorphous phosphate, as well as crystalline or amorphous oxalate. Notably, one of its crystal forms, termed crystal form B, exhibits high crystallinity, low hygroscopicity, and excellent stability. This particular form of phosphate shows promising oral bioavailability, demonstrates good tolerance upon prolonged administration, poses a lower risk of inducing hypoglycemia, and effectively inhibits serum DPPIV.
Career Highlights
Fuzhi Zhang is associated with Cgenetech (Suzhou, China) Co., Ltd., a company that plays a pivotal role in advancing biotechnology and pharmaceuticals. His work encompasses significant discovery and innovation, focused on improving therapeutic agents for better patient outcomes.
Collaborations
Throughout his career, Zhang has collaborated with esteemed colleagues, including Yan Hao and Renyan Zhang. These partnerships have fostered an environment of creativity and progress within the realms of pharmaceutical development.
Conclusion
Fuzhi Zhang stands out as a dedicated inventor whose innovative work in pharmaceutical science signifies the potential for enhanced treatment options. His patent showcases the advancements being made in drug formulation, highlighting his commitment to improving health and wellness through science. As the field continues to evolve, Zhang's contributions will undoubtedly leave a lasting impact.